Alkermes plc. Files 8-K for Routine Disclosures

Ticker: ALKS · Form: 8-K · Filed: 2024-10-09T00:00:00.000Z

Sentiment: neutral

Topics: 8-K, disclosure, routine-filing

TL;DR

Alkermes filed a standard 8-K, no major news.

AI Summary

Alkermes plc. filed an 8-K on October 9, 2024, to report on Regulation FD disclosures and file financial statements and exhibits. The filing does not contain specific financial figures or new material events beyond routine reporting requirements.

Why It Matters

This 8-K filing indicates routine corporate reporting by Alkermes plc., without disclosing new material information that would typically impact stock price.

Risk Assessment

Risk Level: low — The filing is a routine 8-K for disclosures and exhibits, not indicating any new material events or risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Alkermes plc.?

The primary purpose of this 8-K filing is to report on Regulation FD disclosures and to file financial statements and exhibits as of October 9, 2024.

What is the exact date of the earliest event reported in this filing?

The date of the earliest event reported in this filing is October 9, 2024.

What is the company's principal executive office address?

The company's principal executive offices are located at Connaught House, 1 Burlington Road, Dublin 4, Ireland, D04 C5Y6.

What is Alkermes plc.'s telephone number?

Alkermes plc.'s telephone number, including area code, is +353-1-772-8000.

What is the Standard Industrial Classification code for Alkermes plc.?

The Standard Industrial Classification code for Alkermes plc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 503 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2024-10-09 16:07:13

Key Financial Figures

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On October 9, 2024, Alkermes plc hosted an investor event to review its orexin portfolio and development strategy. A copy of the presentation displayed during the investor event is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 7.01, and in Exhibit 99.1 furnished herewith, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

01 Financial Sta tements and Exhibits

Item 9.01 Financial Sta tements and Exhibits. (d) Exhibits EXHIBIT INDEX Exhibit No. Description 99.1 Investor presentation displayed by Alkermes plc on October 9, 2024 . 104 Cover page interactive data file (embedded within the Inline XBRL document). 2 SIGNA TURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ALKERMES PLC Date: October 9, 2024 By: /s/ David J. Gaffin David J. Gaffin Secretary 3

View on Read The Filing